3//SEC Filing
SVLSF VI, LLC 3
Accession 0000899243-18-017457
CIK 0001681087other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 8:00 PM ET
Size
15.3 KB
Accession
0000899243-18-017457
Insider Transaction Report
Form 3
AVROBIO, Inc.AVRO
SV Life Sciences Fund VI, L.P.
10% Owner
Holdings
- (indirect: By SV Life Sciences Fund VI, L.P.)
Series B Preferred Stock
→ Common Stock (1,808,211 underlying) - (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series B Preferred Stock
→ Common Stock (61,908 underlying) - (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series A Preferred Stock
→ Common Stock (312,341 underlying) - (indirect: By SV Life Sciences Fund VI, L.P.)
Series A Preferred Stock
→ Common Stock (9,122,809 underlying)
Holdings
- (indirect: By SV Life Sciences Fund VI, L.P.)
Series B Preferred Stock
→ Common Stock (1,808,211 underlying) - (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series B Preferred Stock
→ Common Stock (61,908 underlying) - (indirect: By SV Life Sciences Fund VI, L.P.)
Series A Preferred Stock
→ Common Stock (9,122,809 underlying) - (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series A Preferred Stock
→ Common Stock (312,341 underlying)
SV Life Sciences Fund VI (GP), L.P.
10% Owner
Holdings
- (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series A Preferred Stock
→ Common Stock (312,341 underlying) - (indirect: By SV Life Sciences Fund VI, L.P.)
Series B Preferred Stock
→ Common Stock (1,808,211 underlying) - (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series B Preferred Stock
→ Common Stock (61,908 underlying) - (indirect: By SV Life Sciences Fund VI, L.P.)
Series A Preferred Stock
→ Common Stock (9,122,809 underlying)
SVLSF VI, LLC
10% Owner
Holdings
- (indirect: By SV Life Sciences Fund VI, L.P.)
Series A Preferred Stock
→ Common Stock (9,122,809 underlying) - (indirect: By SV Life Sciences Fund VI, L.P.)
Series B Preferred Stock
→ Common Stock (1,808,211 underlying) - (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series A Preferred Stock
→ Common Stock (312,341 underlying) - (indirect: By: SV Life Sciences Fund VI Strategic Partners, L.P.)
Series B Preferred Stock
→ Common Stock (61,908 underlying)
Footnotes (3)
- [F1]All series of Convertible Preferred Stock shall automatically convert on a 4.132-for-1 basis into shares of the Issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
- [F2]The shares are held directly by SV Life Sciences Fund VI, L.P. ("SV Life LP"). SV Health Investors, LLC is the Manager of SV Life LP. SV Life Sciences Fund VI (GP), L.P., ("SV Fund VI GP") is the general partner of SV Life LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. The members of the investment committee of SVLSF VI, LLC are Kate Bingham, Thomas Flynn, James Garvey, Eugene D. Hill, III, Paul LaViolette, and Michael Ross. Each of SV Fund VI GP, SVLSF VI, LLC and the SVLSF VI, LLC investment committee disclaims beneficial ownership of the shares owned directly by SV Life LP, except to the extent of any pecuniary interest therein.
- [F3]The shares are held directly by SV Life Sciences Fund VI Strategic Partners, L.P. ("SV Life SP LP"). SV Health Investors, LLC is the Manager of SV Life SP LP. SV Fund VI GP is the general partner of SV Life SP LP. The general partner of SV Fund VI GP is SVLSF VI, LLC. The members of the investment committee of SVLSF VI, LLC are Kate Bingham, Thomas Flynn, James Garvey, Eugene D. Hill, III, Paul LaViolette, and Michael Ross. Each of SV Fund VI GP, SVLSF VI, LLC and the SVLSF VI, LLC investment committee disclaims beneficial ownership of the shares owned directly by SV Life SP LP, except to the extent of any pecuniary interest therein.
Documents
Issuer
AVROBIO, Inc.
CIK 0001681087
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001717728
Filing Metadata
- Form type
- 3
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 8:00 PM ET
- Size
- 15.3 KB